Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3716282 | 0.75 | ALDH1A1 (0.35) | ALDH1A1TSHRMAPK1 | |
| SCHEMBL12618062 | 0.73 | ALDH1A1 (0.33) | ALDH1A1TSHRMAPK1 | |
| SCHEMBL10299030 | 0.71 | ALDH1A1 (0.32) | ALDH1A1TSHRMAPK1 | |
| SCHEMBL15909682 | 0.71 | ALDH1A1 (0.32) | ALDH1A1TSHRMAPK1 | |
| SCHEMBL10723178 | 0.71 | TSHR (0.32) | ALDH1A1TSHRMAPK1 | |
| SCHEMBL297858 | 0.71 | ALDH1A1 (0.32) | ALDH1A1TSHRMAPK1 | |
| SCHEMBL13986670 | 0.71 | ALDH1A1 (0.32) | ALDH1A1TSHRMAPK1 | |
| SCHEMBL27052568 | 0.71 | TSHR (0.38) | ALDH1A1TSHRMAPK1 | |
| SCHEMBL7146135 | 0.69 | TSHR (0.42) | ALDH1A1TSHRMAPK1 | |
| SCHEMBL19978202 | 0.69 | LMNA (0.50) | ALDH1A1TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7572303-B2 | A symmetrical dialkyl carbonate, a metal, borong, silicon, or group 7 compound, a hydrogen or hydrocarbon-based fuel, an oxidizer, and a metallic cocatalyst; minimized hydrolysis; improved combustion and storage stability | OCTANE INTERNATIONAL, LTD. (US) | 2009-08-11 | — | — | US | disclosed |
| US-7232915-B2 | Process for the synthesis of 1,3-diols | WARNER-LAMBERT COMPANY (US) | 2007-06-19 | — | — | US | disclosed |
| EP-1054860-B1 | PROCESS FOR THE SYNTHESIS OF 1,3-DIOLS | PFIZER IRELAND PHARMACEUTICALS (IE) | 2007-04-25 | — | — | EP | disclosed |
| EP-0954558-B1 | FUEL COMPOSITIONS EXHIBITING IMPROVED FUEL STABILITY | ORR WILLIAM C (US) | 2006-06-14 | — | — | EP | disclosed |
| US-6962994-B2 | Process for the synthesis of 1,3-diols | WARNER-LAMBERT COMPANY, LLC (US) | 2005-11-08 | — | — | US | disclosed |
| US-20050197500-A1 | Process for the synthesis of 1,3-diols | BOSCH ROBERT L (US) | 2005-09-08 | — | — | US | disclosed |
| US-20050044778-A1 | Fuel compositions employing catalyst combustion structure | OCTANE INTERNATIONAL, LTD. | 2005-03-03 | — | — | US | disclosed |
| US-20040237384-A1 | Fuel compositions exhibiting improved fuel stability | OCTANE INTERNATIONAL, LTD. | 2004-12-02 | — | — | US | disclosed |
| US-20040006231-A1 | Process for the synthesis of 1,3-diols | BOSCH ROBERT LEE (US) | 2004-01-08 | — | — | US | disclosed |
| US-6652608-B1 | Fuel compositions exhibiting improved fuel stability | OCTANE INTERNATIONAL, LTD. | 2003-11-25 | — | — | US | disclosed |
| US-6596879-B2 | Beta hydroxy ketone treated with trialkylborane or dialkylalkoxyborane followed by recovery and reuse of alkylborane | WARNER-LAMBERT COMPANY | 2003-07-22 | — | — | US | disclosed |
| US-20020161021-A1 | Process for the synthesis of 1,3-diols | BOSCH ROBERT LEE (US) | 2002-10-31 | — | — | US | disclosed |
| US-6433213-B1 | REDUCTION USING BORON COMPOUND | WARNER-LAMBERT COMPANY | 2002-08-13 | — | — | US | disclosed |
| EP-1054860-A1 | PROCESS FOR THE SYNTHESIS OF 1,3-DIOLS | Warner-Lambert Export Limited (IE) | 2000-11-29 | — | — | EP | disclosed |
| EP-1051461-A2 | FUEL COMPOSITIONS EMPLOYING CATALYST COMBUSTION STRUCTURE | ORR, William C. (US) | 2000-11-15 | — | — | EP | disclosed |
| WO-1999066009-A2 | FUEL COMPOSITIONS EMPLOYING CATALYST COMBUSTION STRUCTURE | ORR WILLIAM C (US) | 1999-12-23 | — | — | WO | disclosed |
| EP-0954558-A1 | FUEL COMPOSITIONS EXHIBITING IMPROVED FUEL STABILITY | ORR, William C. (US) | 1999-11-10 | — | — | EP | disclosed |
| WO-1999032434-A1 | PROCESS FOR THE SYNTHESIS OF 1,3-DIOLS | WARNER-LAMBERT EXPORT LIMITED (IE) | 1999-07-01 | — | — | WO | disclosed |
| WO-1998026028-A1 | FUEL COMPOSITIONS EXHIBITING IMPROVED FUEL STABILITY | ORR WILLIAM C (US) | 1998-06-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050197500-A1 | Process for the synthesis of 1,3-diols | HSD17B7, HSD11B1, BCKDK | ALDH1A1 307/4885TSHR 2963/4885MAPK1 372/4885 |
| US-20020161021-A1 | Process for the synthesis of 1,3-diols | HSD17B7, HSD11B1, BCKDK | ALDH1A1 307/4885TSHR 2963/4885MAPK1 372/4885 |
| US-20040006231-A1 | Process for the synthesis of 1,3-diols | HSD17B7, HSD11B1, BCKDK | ALDH1A1 307/4885TSHR 2963/4885MAPK1 372/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.